Enguent Jean-Pierre 4
4 · SEALSQ Corp · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
SEALSQ (LAES) VP Enguent Jean-Pierre Sells 15,000 Shares
What Happened
Enguent Jean-Pierre, Vice President, R&DSS at SEALSQ Corp (ticker LAES), reported multiple transactions around June 1–3, 2026. The primary cash transaction: Jean-Pierre sold 15,000 shares in an open-market sale on June 3, 2026, at a weighted average price of $3.51 for proceeds of approximately $52,652. Earlier on June 1, Jean-Pierre exercised options to acquire 15,000 shares at $0.01 (cost $150) and was also recorded as acquiring a 60,000-share award (derivative) at no cash cost. A separate derivative entry on June 1 shows disposition of 15,000 shares at $0.00 (derivative settlement).
Key Details
- Sale: 15,000 shares disposed on 2026-06-03, weighted average price $3.51, total proceeds ≈ $52,652 (sales executed at $3.44–$3.66; weighted average reported).
- Option exercise/acquisitions on 2026-06-01: 15,000 shares exercised at $0.01 (cost $150) and a 60,000-share award (derivative) recorded at $0.00. Another 15,000-share derivative disposition on 2026-06-01 is shown at $0.00.
- Footnotes: Sales and the option exercise were executed under a pre-established Rule 10b5-1 trading plan adopted October 13, 2025. The reported sale price is a weighted average across multiple trades; the filer can provide per-trade details on request.
- Filing timeliness: Report filed 2026-06-03 for transactions dated 2026-06-01 — within the SEC’s two-business-day Form 4 reporting window.
- Shares owned after the transactions: Not specified in the provided filing details.
Context
- The filing mixes derivative activity (option exercise and an award) with an open-market sale. Exercising options and then selling some or all of the resulting shares is common (can be a cash-raising or diversification action); here the sale followed the June 1 exercises and occurred June 3.
- The sale was conducted under a 10b5-1 plan, which typically indicates pre-planned transactions rather than ad-hoc trading based on recent nonpublic information.
- These records are factual disclosures of insider activity; they do not, by themselves, indicate the insider’s outlook on the company.
Insider Transaction Report
- Exercise/Conversion
Ordinary Shares
2026-06-01$0.01/sh+15,000$150→ 15,000 total - Sale
Ordinary Shares
[F1][F2]2026-06-03$3.51/sh−15,000$52,652→ 0 total - Award
Employee Stock Option Plan (right to buy)
2026-06-01+60,000→ 60,000 totalExercise: $0.01From: 2026-06-01Exp: 2032-04-30→ Ordinary Shares (60,000 underlying) - Exercise/Conversion
Employee Stock Option Plan (right to buy)
[F3]2026-06-01−15,000→ 45,000 totalExercise: $0.01From: 2026-06-01Exp: 2032-04-30→ Ordinary Shares (15,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.44 to $3.66, inclusive. The reporting person undertakes to provide to SEALSQ Corp, any security holder of SEALSQ Corp, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]The options exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.